Spectris plc (LON:SXS)

Revance Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	87.4	105.7	138.5	228.1	167.8	222.2
Cash & Short-Term Investments	87.4	105.7	138.5	228.1	167.8	222.2
Cash Growth	-70.12%	-23.68%	-39.28%	35.94%	-24.48%	4.27%
Accounts Receivable	322	295.4	247.4	293.5	251.2	240.3
Other Receivables	9.5	36.7	49.6	48.8	41.3	34.7
Receivables	331.5	332.1	297	342.3	292.5	275
Inventory	266.2	250.2	231.8	263.3	187.9	168.5
Prepaid Expenses	-	32.1	27.6	28.8	29.1	22.4
Other Current Assets	6.1	1.9	103.8	3	10.7	180.6
Total Current Assets	691.2	722	798.7	865.5	688	868.7
Property, Plant & Equipment	247.7	242.4	194.3	220.4	211	187.1
Long-Term Investments	53.8	53.1	56.8	51.1	47.3	39.4
Goodwill	1,042	1,088	565.5	606.1	631.5	577
Other Intangible Assets	370.1	421.3	167.1	184.1	169.1	107.8
Long-Term Deferred Tax Assets	24.2	22.2	26.6	16.2	21.2	16.2
Other Long-Term Assets	15	10.8	8.7	4.6	-	-
Total Assets	2,444	2,559	1,818	1,948	1,768	1,796
Accounts Payable	338	50.1	42.8	62.8	59.7	51.6
Accrued Expenses	-	107.2	142.5	141	125.7	113.4
Short-Term Debt	6.3	13.3	-	0.1	-	13.1
Current Portion of Leases	18.3	22.1	14.4	14.9	16.6	12.9
Current Income Taxes Payable	5.2	6.3	12.6	14.2	28.1	15.6
Current Unearned Revenue	-	106.6	85.5	98.4	77.9	59.6
Other Current Liabilities	20.9	89.8	125	86.6	85.7	125.8
Total Current Liabilities	388.7	395.4	422.8	418	393.7	392
Long-Term Debt	626.8	641.4	-	-	-	104.5
Long-Term Leases	58.2	54.6	48.3	50.2	49.3	26
Long-Term Unearned Revenue	-	3.1	4	3.9	3.4	9.9
Long-Term Deferred Tax Liabilities	36.4	44.6	1.3	15.6	23	5.1
Other Long-Term Liabilities	18.2	28.5	13.8	14.5	15.1	18.6
Total Liabilities	1,139	1,179	501.8	511.1	506.8	576.5
Common Stock	5.2	5.2	5.3	5.5	5.8	6
Additional Paid-In Capital	231.4	231.4	231.4	231.4	231.4	231.4
Retained Earnings	1,099	1,138	1,030	1,113	957.6	882.6
Comprehensive Income & Other	-30.3	5.6	49.2	87	66.5	99.7
Shareholders' Equity	1,305	1,381	1,316	1,437	1,261	1,220
Total Liabilities & Equity	2,444	2,559	1,818	1,948	1,768	1,796
Total Debt	709.6	731.4	62.7	65.2	65.9	156.5
Net Cash (Debt)	-622.2	-625.7	75.8	162.9	101.9	65.7
Net Cash Growth	-	-	-53.47%	59.86%	55.10%	-
Net Cash Per Share	-6.20	-6.19	0.73	1.50	0.89	0.57
Filing Date Shares Outstanding	99	98.8	101.62	104.49	110.77	116.19
Total Common Shares Outstanding	99	98.8	101.62	104.49	110.77	116.19
Working Capital	302.5	326.6	375.9	447.5	294.3	476.7
Book Value Per Share	13.19	13.97	12.95	13.75	11.39	10.50
Tangible Book Value	-106.8	-128.2	583.3	646.7	460.7	534.9
Tangible Book Value Per Share	-1.08	-1.30	5.74	6.19	4.16	4.60
Machinery	-	165.9	156.7	192.2	191.7	189.3
Construction In Progress	-	25.7	15.4	15.4	5.9	14.3

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.